Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

NCT: NCT06784063 · COMPLETED

NCT IDNCT06784063
StatusCOMPLETED
Start Date2025-04-10
Completion2025-06-13
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑